Postmarket Problems: FDA Struggles To Achieve Manufacturer Compliance
This article was originally published in The Gray Sheet
Executive Summary
CDRH's cardiovascular review division has faced resistance from PMA sponsors in complying with post-approval study requirements that involve new patient registries, an official from the division reported May 9 at the North American Society of Pacing and Electrophysiology annual meeting